Absence of retroviral vector-mediated transformation of gene-modified T cells after long-term engraftment in mice (Q45876227)

17 December 2017

title

Absence of retroviral vector-mediated transformation of gene-modified T cells after long-term engraftment in mice (English)

1 reference

17 December 2017

1 reference

17 December 2017

Stephen Fox

1 reference

17 December 2017

Phillip K. Darcy

1 reference

17 December 2017

Michael H. Kershaw

1 reference

17 December 2017

Mark J. Smyth

object named as

M J Smyth

1 reference

17 December 2017

Joseph A. Trapani

object named as

J A Trapani

1 reference

17 December 2017

author name string

J A Westwood

1 reference

17 December 2017

W K Murray

1 reference

17 December 2017

M Trivett

1 reference

17 December 2017

A Shin

1 reference

17 December 2017

D P MacGregor

1 reference

17 December 2017

N M Haynes

1 reference

17 December 2017

P Mayura-Guru

1 reference

17 December 2017

S Peinert

1 reference

17 December 2017

D Honemann

1 reference

17 December 2017

H M Prince

1 reference

17 December 2017

D Ritchie

1 reference

17 December 2017

A M Scott

1 reference

17 December 2017

F E Smyth

1 reference

17 December 2017

publication date

27 March 2008

1 reference

17 December 2017

published in

Gene Therapy

1 reference

17 December 2017

volume

1 reference

17 December 2017

issue

1 reference

17 December 2017

page(s)

1056-1066

1 reference

17 December 2017

Correction of murine hemophilia A by hematopoietic stem cell gene therapy

cites work

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.47

High-level expression of porcine factor VIII from genetically modified bone marrow-derived stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.47

Development of virus vectors for gene therapy of beta chain hemoglobinopathies: flanking with a chromatin insulator reduces gamma-globin gene silencing in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.47

Partial correction of murine beta-thalassemia with a gammaretrovirus vector for human gamma-globin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.47

Long-term expression of gamma-globin mRNA in mouse erythrocytes from retrovirus vectors containing the human gamma-globin gene fused to the ankyrin-1 promoter

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.47

Vaccination with irradiated autologous melanoma cells engineered to secrete human granulocyte-macrophage colony-stimulating factor generates potent antitumor immunity in patients with metastatic melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.47

Gene modification strategies to induce tumor immunity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.47

Cancer regression in patients after transfer of genetically engineered lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.47

T lymphocyte-directed gene therapy for ADA- SCID: initial trial results after 4 years.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.47

Gene therapy in peripheral blood lymphocytes and bone marrow for ADA- immunodeficient patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.47

Persistence and expression of the adenosine deaminase gene for 12 years and immune reaction to gene transfer components: long-term results of the first clinical gene therapy trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.47

Correction of ADA-SCID by stem cell gene therapy combined with nonmyeloablative conditioning

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.47

Gene therapy of X-linked severe combined immunodeficiency by use of a pseudotyped gammaretroviral vector

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.47

Sustained correction of X-linked severe combined immunodeficiency by ex vivo gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.47

Correction of X-linked chronic granulomatous disease by gene therapy, augmented by insertional activation of MDS1-EVI1, PRDM16 or SETBP1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.47

Retroviral DNA integration: viral and cellular determinants of target-site selection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.47

Transcription start regions in the human genome are favored targets for MLV integration

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.47

Insertional mutagenesis identifies genes that promote the immortalization of primary bone marrow progenitor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.47

Clonal dominance of hematopoietic stem cells triggered by retroviral gene marking.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.47

Gene therapy: therapeutic gene causing lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.47

Cooperating cancer-gene identification through oncogenic-retrovirus-induced insertional mutagenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.47

Unique risk factors for insertional mutagenesis in a mouse model of XSCID gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.47

Acute myeloid leukemia is associated with retroviral gene transfer to hematopoietic progenitor cells in a rhesus macaque

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.47

A serious adverse event after successful gene therapy for X-linked severe combined immunodeficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.47

Vector integration is nonrandom and clustered and influences the fate of lymphopoiesis in SCID-X1 gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.47

Long-term restoration of immunity against Epstein-Barr virus infection by adoptive transfer of gene-modified virus-specific T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.47

Rejection of Syngeneic Colon Carcinoma by CTLs Expressing Single-Chain Antibody Receptors Codelivering CD28 Costimulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.47

Single-chain antigen recognition receptors that costimulate potent rejection of established experimental tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.47

Suppression of lymphoma and epithelial malignancies effected by interferon gamma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.47

Perforin-mediated cytotoxicity is critical for surveillance of spontaneous lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.47

Dose finding with retroviral vectors: correlation of retroviral vector copy numbers in single cells with gene transfer efficiency in a cell population

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.47

Molecular analysis of T lymphocyte-directed gene therapy for adenosine deaminase deficiency: long-term expression in vivo of genes introduced with a retroviral vector

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.47

A phase I study on adoptive immunotherapy using gene-modified T cells for ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.47

Gene-modified T cells for adoptive immunotherapy of renal cell cancer maintain transgene-specific immune functions in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.47

Adoptive cell transfer therapy following non-myeloablative but lymphodepleting chemotherapy for the treatment of patients with refractory metastatic melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.47

Removal of homeostatic cytokine sinks by lymphodepletion enhances the efficacy of adoptively transferred tumor-specific CD8+ T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.47

Interleukin-7-dependent expansion and persistence of melanoma-specific T cells in lymphodepleted mice lead to tumor regression and editing.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.47

LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.47

Construction, expression and characterisation of a single-chain diabody derived from a humanised anti-Lewis Y cancer targeting antibody using a heat-inducible bacterial secretion vector

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.47

A phase I biodistribution and pharmacokinetic trial of humanized monoclonal antibody Hu3s193 in patients with advanced epithelial cancers that express the Lewis-Y antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.47

Adoptive transfer of T cells modified with a humanized chimeric receptor gene inhibits growth of Lewis-Y-expressing tumors in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.47

Development and analysis of retroviral vectors expressing human factor VIII as a potential gene therapy for hemophilia A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.47

Redesign of retrovirus packaging cell lines to avoid recombination leading to helper virus production

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.47

Generation of anti-idiotype antibodies for application in clinical immunotherapy laboratory analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.47

Murine leukemia induced by retroviral gene marking

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.47

inferred from DOI database lookup

7 January 2021

based on heuristic

Safety of retroviral gene marking with a truncated NGF receptor

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.47

inferred from DOI database lookup

7 January 2021

based on heuristic

Dietary restriction in mice beginning at 1 year of age: effect on life-span and spontaneous cancer incidence

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.47

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/GT.2008.47

1 reference

17 December 2017

Dimensions Publication ID

1050374320

0 references

1 reference

17 December 2017